KEDI U.S. Humanoid Robot Index

Honeywell Aerospace spin-off is scheduled to be completed on June 29, 2026, marking the final step in the company's portfolio transformation. The new company will trade under the ticker 'HONA'. This event is scheduled.

A quarterly dividend of $1.19 per share is scheduled to be paid on June 5, 2026, to shareholders of record as of May 17, 2026. This event is scheduled.

Medtronic is scheduled to report its financial results for the fourth quarter and full fiscal year 2026 on June 3, 2026. This event is expected to have a medium impact as earnings reports typically drive significant price volatility scheduled.

NVIDIA is scheduled to announce its financial results for the first quarter of fiscal year 2027, which ended on April 26, 2026, after market close on May 20, 2026. High importance is estimated as earnings reports typically trigger significant price movement, scheduled.

First quarter 2026 financial results are scheduled to be released before the market opens on May 12, 2026; Medium importance estimated as earnings releases typically cause significant price volatility scheduled.

Microchip's Q4 and full fiscal year 2026 financial results conference call is scheduled for May 7, 2026. Analysts forecast revenue of approximately $1.26 billion and an adjusted EPS of $0.50. The market has priced in a potential post-earnings price move of over 11%, justifying the high importance scheduled.

AMD fiscal Q1 2026 earnings results are scheduled to be released after market close on May 5, 2026; high impact expected as earnings typically drive >10% price volatility, scheduled.

Rockwell Automation is scheduled to report its second quarter fiscal 2026 results on May 5, 2026, before the market opens, with a conference call to follow; Medium importance is estimated as earnings reports typically drive significant price volatility, scheduled

Alphabet reported Q1 2026 revenue of $109.9 billion and EPS of $5.11, significantly beating analyst estimates of $107 billion and $2.67, respectively. High importance is estimated due to the massive EPS beat which is expected to drive a >10% price impact, expected.

Reported Q1 2026 financial results on 2026-04-29, beating revenue and adjusted EPS estimates. However, the company raised its full-year capital expenditure guidance to $125-$145 billion, causing the stock to decline over 6% in after-hours trading.

Microsoft announced fiscal Q3 2026 results on April 29, 2026, with revenue of $82.9 billion and EPS of $4.27, beating analyst estimates. Azure revenue grew 40%. A 5% or greater price impact is estimated based on the significant earnings beat, expected.

Medtronic received U.S. Food and Drug Administration (FDA) approval for the Mosaic Neo mitral valve, its next-generation mitral bioprosthesis, on April 29, 2026.

Reported Q2 2026 revenue of $10.6B (down 3% YoY) and non-GAAP EPS of $2.65, beating estimates. Issued Q3 revenue guidance of $9.2B-$10.0B and EPS of $2.10-$2.30, below consensus due to memory supply constraints. Stock fell ~4.5% in after-hours trading.

Announced a strategic investment in Apera AI on April 29, 2026, a company developing AI-powered vision software for robotics.

Reported Q1 2026 revenue of $1.282 billion and non-GAAP EPS of $2.56 on 2026-04-28, beating analyst estimates. Despite the strong results driven by AI-related demand, the company's stock fell over 10% in subsequent trading, reportedly due to concerns over future growth and valuation.

AMD announced its 'Advancing AI 2026' event on April 28, 2026, scheduled for July 23, 2026; medium impact expected as major event announcements typically influence price by ~5%.

Northland Capital Markets downgraded AMD stock to Market Perform on April 27, 2026; low impact expected as single analyst actions typically cause 1-3% price movement.

Microsoft and OpenAI announced amended partnership terms on April 27, 2026, granting OpenAI more flexibility and making Microsoft's IP license non-exclusive. A 1% or greater price impact is estimated due to the structural partnership adjustment, expected.

Announced plans on 2026-04-24 to reduce its workforce by approximately 10%, or 8,000 jobs, to enhance efficiency and reallocate resources towards investments in artificial intelligence. This is estimated to have a medium impact (≥5%) due to the significant scale of restructuring.

Alphabet announced its annual meeting for June 5, 2026, and filed proxy materials on April 24, 2026, including a proposal to add 200 million Class C shares to its 2021 Stock Plan. Low importance is estimated as this is a routine filing with expected <5% price impact, expected.

Medtronic disclosed in an 8-K filing on April 24, 2026, that it had identified unauthorized access to some of its IT systems, though no material impact is expected.